Pandox's objective is to generate a good risk-adjusted total return in the company's shares.

Pandox is listed on Nasdaq Stockholm Large Cap under the trade symbol PNDX B, since 18 June, 2015. The total number of diluted outstanding shares is 167,499,999, whereof 75,000,000 A shares and 92,499,999 B shares.

The information is delayed by 15 minutes.